Clinical trial
Greater Occipital Nerve Block for Migraine Prophylaxis
NCT00915473 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00915473 |
|---|---|
| Title | Greater Occipital Nerve Block for Migraine Prophylaxis |
| Official title | Greater Occipital Nerve Block for Migraine Prophylaxis |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Center for Advancing Translational Sciences (NCATS) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Migraine Headache |
| Intervention type | Drug |
| Interventions | bupivicaine, normal saline, methylprednisolone, lidocaine |
| Enrollment | 70 |
| Start date | Jun 1, 2009 |
| Primary completion | Jan 1, 2013 |
| Completion | Jan 1, 2013 |
| First posted | Jun 8, 2009 |
| Last update posted | Mar 20, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: